Diagnosis and treatment of therapy-related acute myeloid leukemia.
Strickland SA, Vey N.
Crit Rev Oncol Hematol. 2022 Mar;171:103607. doi: 10.1016/j.critrevonc.2022.103607. Epub 2022 Jan 31.
Progress toward Better Treatment of Therapy-Related AML.
Kotsiafti A, Giannakas K, Christoforou P, Liapis K.
Cancers (Basel). 2023 Mar 8;15(6):1658. doi: 10.3390/cancers15061658.
Clonal Hematopoiesis and therapy related MDS/AML.
Desai P, Roboz GJ.
Best Pract Res Clin Haematol. 2019 Mar;32(1):13-23. doi: 10.1016/j.beha.2019.02.006. Epub 2019 Feb 15.
TP53 mutation defines a unique subgroup within complex karyotype de novo and therapy-related MDS/AML.
Weinberg OK, Siddon A, Madanat YF, Gagan J, Arber DA, Dal Cin P, Narayanan D, Ouseph MM, Kurzer JH, Hasserjian RP.
Blood Adv. 2022 May 10;6(9):2847-2853. doi: 10.1182/bloodadvances.2021006239.
Therapy-related myeloid neoplasms.
Ganser A, Heuser M.
Curr Opin Hematol. 2017 Mar;24(2):152-158. doi: 10.1097/MOH.0000000000000316.
Therapy related AML in a case of chronic lymphocytic leukemia.
Gajendra S, Jha B, Sharma R.
Am J Blood Res. 2023 Apr 15;13(2):77-83. eCollection 2023.
Therapy-Related Myeloid Neoplasms.
Bueso-Ramos CE, Kanagal-Shamanna R, Routbort MJ, Hanson CA.
Am J Clin Pathol. 2015 Aug;144(2):207-18. doi: 10.1309/AJCPU1JO2LYTWUAV.
What is new in acute myeloid leukemia classification?
Park HS.
Blood Res. 2024 Apr 15;59(1):15. doi: 10.1007/s44313-024-00016-8.
Daunorubicin and Cytarabine Liposome in Newly Diagnosed Therapy-Related Acute Myeloid Leukemia (AML) or AML With Myelodysplasia-Related Changes.
Kim M, Williams S.
Ann Pharmacother. 2018 Aug;52(8):792-800. doi: 10.1177/1060028018764923. Epub 2018 Mar 13.
On the road to improved therapies for therapy-related AML.
Stevens AM, Cooper TM.
Blood Adv. 2025 Jun 10;9(11):2842-2844. doi: 10.1182/bloodadvances.2025015987.
